Search for European Projects

10 European Projects Found

Searched on 125080 European Projects

 FINISHED 

AnTBiotic – progressing TB drug candidates to clinical proof of concept (anTBiotic)

Start date: Jan 1, 2017, End date: Dec 31, 2021,

Tuberculosis (TB) today rivals HIV/AIDS as the leading cause of death from infectious diseases. The number of TB patients has never been higher and the growing proportion of drug-resistant TB is threatening control strategies both in the developing and developed world, Eastern Europe being a particularly worrying point in case. The anTBiotic consortium aims to fuel the long-term TB clinical pipeli ...
Read Project

 5

 FINISHED 

Graphene-based disruptive technologies (GrapheneCore1)

Start date: Apr 1, 2016, End date: Mar 31, 2018,

This project is the second in the series of EC-financed parts of the Graphene Flagship. The Graphene Flagship is a 10 year research and innovation endeavour with a total project cost of 1,000,000,000 euros, funded jointly by the European Commission and member states and associated countries. The first part of the Flagship was a 30-month Collaborative Project, Coordination and Support Action (CP-CS ...
Read Project

 158

 FINISHED 

Hit to lead optimisation of novel anti-TB scaffolds through an academic-industrial partnership (Coopera-TB)

Start date: Feb 1, 2014, End date: Jan 31, 2018,

We propose a PhD programme for 4 Early-Stage Researchers (ESR) in tuberculosis (TB) drug discovery. Often associated with poverty, TB is rampant in many parts of Africa and Asia but has now also returned to developed nations. Growing resistance against currently used antibiotics is one of the most pressing problems of the global TB epidemic. Treating TB infections requires a drug cocktail given fo ...
Read Project

 2

 FINISHED 

Nanotherapeutics for antibiotic resistant emerging bacterial pathogens (NAREB)

Start date: Feb 1, 2014, End date: Jan 31, 2018,

Increase in antibiotic resistance is a global concern worldwide. The project NAREB's main objective is the optimization of several nanoformulations of antibacterial therapeutics in order to improve the therapy of multi-drug resistant (MDR) tuberculosis (TB) and MRSA infections in European MDR patients.NAREB will address the problem of drug bioavailability inside the infected macrophages, transport ...
Read Project

 16

 FINISHED 

Model-based preclinical development of anti-tuberculosis drug combinations (PREDICT-TB)

Start date: May 1, 2012, End date: Oct 30, 2017,

Drug development in TB requires new integrated methods to transition the novel combination regimens needed to shorten first-line therapy and combat multi-drug resistance. Although new agents are emerging, the path to registration of such regimens remains uncertain while capacity for pivotal trials is limited. Selection and optimization of drug combinations for development depends on preclinical sy ...
Read Project

 23

 FINISHED 

Medicinal Chemistry Open Innovation Doctorates (OpenMedChem)

Start date: Oct 1, 2012, End date: Sep 30, 2016,

The establishment of influential public and private public partnerships fostering true collaboration between big Pharma and universities for a non-profit end goal has opened the door for stronger interaction and integration. This structural change has come to stay and is slowly permeating other sectors in which the commercial return on investment is clear (Drug. Discov. Today, 2009, 14, 1003). Thi ...
Read Project

 2

 FINISHED 

A systematic analysis of parasite metabolism - from metabolism to intervention (ParaMet)

Start date: Jun 1, 2012, End date: May 31, 2016,

Parasites exact a devastating toll on health and economic productivity, infecting man and also domestic livestock. Drugs used to combat parasitic diseases are deficient in many ways and new, better drugs are needed to establish sustainable means to combat diseases caused by protozoan parasites that include malaria, trypanosomiasis and leishmaniasis in man, and coccidiosis among others in animals. ...
Read Project

 12

 FINISHED 

Training Network on Zebrafish Infection Models for Pharmaceutical Screens (FishForPharma)

Start date: Jan 1, 2012, End date: Dec 31, 2015,

Infectious diseases caused by pathogenic micro-organisms are major causes of death, disability, and social and economic disruption for millions of people. During evolution these pathogens have developed intricate strategies to manipulate host defence mechanisms and outwit the immune system. To reduce the burden of infectious diseases it is important to increase understanding of these host-pathogen ...
Read Project

 10

 FINISHED 

European Research Training in the Ubiquitin Proteasome System (UPStream)

Start date: Nov 1, 2011, End date: Oct 31, 2015,

The main objective of the international training network UPStream is the training of a novel generation of European scientist in a critical and complex field of modern biology: the understanding of the regulation of the UPS and its potential use for drug development. The importance of this process is illustrated by the imperious necessity to destroy certain proteins during several phases of the ce ...
Read Project

 10

 FINISHED 

Open Collaborative Model for Tuberculosis Lead Optimisation (ORCHID)

Start date: Jan 1, 2011, End date: Jun 30, 2015,

"Early stage Drug Discovery efforts over the last 5 years have resulted in the identification of a number of promising lead compounds in the fight against TB. These leads need to be further progressed and optimised into candidates for pre-clinical development through the Drug Development progression cascade.Three compound families are of particular interest: 1) InhA Inhibitors, 2) New potent whole ...
Read Project

 14